Rep. Frank Lucas (R-OK-3) sat down with the Hudson Institute on Monday for a one hour event on how to counter China economically and the biggest takeaway was the obvious: it won’t be easy, and everyone has a different opinion on it.
According to expert testimony given by the witnesses, the crisis is being fueled by poor manufacturing practices that have led to recalls by foreign drug manufacturers, and the race to the bottom on generic drug prices that make it impossible for American generic drug makers to compete with subsidized competitors in India and China.
The annual trade deficit has fallen. Yet for 2023, our trade deficit of $773 billion was once again the world’s largest. Our goods deficit, at $1.06 trillion, exceeded a trillion dollars for the third year in a row.
Notes from the latest U.S. China Economic and Security Review Commission hearing. Tech dependence levels still staggering.
The Ranking Member of the House Financial Services Committee calls for more details about Silicon Valley’s China portfolio.
Should the Chinese EV battery making company Gotion High-Tech get benefits under the Inflation Reduction Act? Rep. John Moolenaar wants to know.
The Active Pharmaceutical Ingredient Innovation Center (APIIC), a consortium of biotechnology industry, policy and academic leaders, said in a whitepaper released to the media on Jan. 24, that reshoring the manufacture of essential, life-saving pharmaceuticals was urgently needed.
Homeland Security and U.S. Customs face a daunting task in policing the millions of packages full of textile fabrics and apparel that come into the country duty free. They know it. What can be done about it, is the question.
The capacity for China to overproduce anything is legion. This is especially true for big ticket items sold around the world, from cars to steel to China’s top green tech product line – solar cells and modules.
Nelson Cunningham would be the second in command at the USTR after Katherine Tai in his role as Deputy United States Trade Representative.
